Effective treatment of a patient with stage IV ovarian cancer: A case report

被引:9
|
作者
Huang, Zhen [1 ]
Yan, Hua [2 ]
Chavan, Devendra [1 ]
Yuan, Zeng [1 ]
Yang, Xingsheng [1 ]
Zhang, Youzhong [1 ]
Song, Kun [1 ]
Kong, Beihua [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Spleen & Stomach Dis, Jinan 250012, Shandong, Peoples R China
关键词
interval cytoreductive surgery; neoadjuvant chemotherapy; post-surgery chemotherapy; ovarian neoplasms; treatment; PEGYLATED LIPOSOMAL DOXORUBICIN; DEBULKING SURGERY; CHEMOTHERAPY; TRABECTEDIN;
D O I
10.3892/ol.2017.7285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present case report describes a patient with stage IV ovarian cancer who survived for 9 years without achieving a complete remission since the first relapse. The patient's long-term survival may be ascribed to the slow growth of the cancer cells, limited metastasis and favorable responses to the treatments received. The patient manifested initially with malignant pleural effusion and was not able to tolerate surgical treatment. However, the disease was well-controlled using various treatments, including neoadjuvant chemotherapy, interval cytoreductive surgery and post-operative long-term chemotherapy. Management of ovarian cancer is most effective when tailored to the individual needs of the patient, maximizing its efficacy and prolonging the patient's survival rate. The present case may offer useful insight into the clinical management of stage IV ovarian cancer
引用
收藏
页码:588 / 591
页数:4
相关论文
共 50 条
  • [1] Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report
    Mitamura, Takashi
    Hosaka, Masayoshi
    Takeda, Mahito
    Watari, Hidemichi
    Sakuragi, Noriaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 169 - 170
  • [2] Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report
    Takashi Mitamura
    Masayoshi Hosaka
    Mahito Takeda
    Hidemichi Watari
    Noriaki Sakuragi
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 169 - 170
  • [3] Ukrain treatment in a patient with stage IV neuroblastoma. A case report
    Aschhoff, B
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1998, 24 (5-6) : 243 - 245
  • [4] Symptom management in a patient with end-stage ovarian cancer: case report
    Moretti, R.
    Pizzi, B.
    Colizza, M. T.
    Carta, G.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (04) : 325 - 327
  • [5] Pneumocystis carinii pneumonia in a patient with stage IV ovarian cancer
    Watanabe, M
    Aoki, Y
    Kurata, H
    Tanaka, K
    GYNECOLOGIC ONCOLOGY, 2002, 87 (02) : 225 - 227
  • [6] Successful treatment of a patient with stage IV rhabdoid tumor of the kidney: Case report and review
    Waldron, PE
    Rodgers, BM
    Kelly, MD
    Womer, RB
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (01) : 53 - 57
  • [7] Protocol for Desensitization to Trastuzumab in a Patient With Anaphylaxis and Stage IV Breast Cancer: A Case Report
    de Lira-Quezada, C. E.
    Villarreal-Gonzalez, R. V.
    Gonzalez-Diaz, S. N.
    Acuna-Ortega, N.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (05) : 376 - 377
  • [8] Carboplatin-induced scleroderma in a patient with stage IV ovarian cancer
    Viet Nguyen
    Nydorf, Ethan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB137 - AB137
  • [9] Cardiac tamponade during pembrolizumab treatment in a patient with ovarian cancer: a case report
    Sung, Wei-Ting
    Sakai, Kunihiro
    Etou, Haruka
    Yamamichi, Rikiko
    Yoneda, Tomoko
    Matsuura, Toshiaki
    Maruyama, Tomoyoshi
    Nishi, Daisuke
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2023, 12 (04) : 305 - 310
  • [10] Cardiac tamponade during pembrolizumab treatment in a patient with ovarian cancer: a case report
    Wei-Ting Sung
    Kunihiro Sakai
    Haruka Etou
    Rikiko Yamamichi
    Tomoko Yoneda
    Toshiaki Matsuura
    Tomoyoshi Maruyama
    Daisuke Nishi
    International Cancer Conference Journal, 2023, 12 : 305 - 310